I like what I am hearing about this drug... i am actually in for50k @ .135... the ONE thing that kinda bothers me is that the only study conducted for this drug was not done in the US but In Argentina...anyone have any insight into how the FDA views studies not conducted in the US??
By the way, do you mean the study conducted in South Korea by Shin Poong, one of the largest drug makers in Asia? Surely FDA doesn't care about pre-clinicals so much. But an abbreviated FDA clinical ought to bode well.